Long non-coding RNAs as master regulators in cardiovascular diseases

Krystal Archer, Zuzana Broskova, Ahmed S. Bayoumi, Jian Peng Teoh, Alec Davila, Yaoliang Tang, Huabo Su, Il Man Kim

Research output: Contribution to journalReview article

64 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of death in the United States, accounting for nearly one in every seven deaths. Over the last decade, various targeted therapeutics have been introduced, but there has been no corresponding improvement in patient survival. Since the mortality rate of cardiovascular disease has not been significantly decreased, efforts have been made to understand the link between heart disease and novel therapeutic targets such as non-coding RNAs. Among multiple non-coding RNAs, long non-coding RNA (lncRNA) has emerged as a novel therapeutic in cardiovascular medicine. LncRNAs are endogenous RNAs that contain over 200 nucleotides and regulate gene expression. Recent studies suggest critical roles of lncRNAs in modulating the initiation and progression of cardiovascular diseases. For example, aberrant lncRNA expression has been associated with the pathogenesis of ischemic heart failure. In this article, we present a synopsis of recent discoveries that link the roles and molecular interactions of lncRNAs to cardiovascular diseases. Moreover, we describe the prevalence of circulating lncRNAs and assess their potential utilities as biomarkers for diagnosis and prognosis of heart disease.

Original languageEnglish (US)
Pages (from-to)23651-23667
Number of pages17
JournalInternational journal of molecular sciences
Volume16
Issue number10
DOIs
StatePublished - Oct 5 2015

Fingerprint

Long Noncoding RNA
regulators
RNA
Cardiovascular Diseases
heart diseases
Untranslated RNA
death
Heart Diseases
pathogenesis
prognosis
mortality
biomarkers
gene expression
nucleotides
molecular interactions
medicine
progressions
Molecular interactions
Biomarkers
Nucleotides

Keywords

  • Chromatin
  • Epigenetic regulation
  • Gene regulation
  • Heart disease
  • Non-coding RNAs

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Archer, K., Broskova, Z., Bayoumi, A. S., Teoh, J. P., Davila, A., Tang, Y., ... Kim, I. M. (2015). Long non-coding RNAs as master regulators in cardiovascular diseases. International journal of molecular sciences, 16(10), 23651-23667. https://doi.org/10.3390/ijms161023651

Long non-coding RNAs as master regulators in cardiovascular diseases. / Archer, Krystal; Broskova, Zuzana; Bayoumi, Ahmed S.; Teoh, Jian Peng; Davila, Alec; Tang, Yaoliang; Su, Huabo; Kim, Il Man.

In: International journal of molecular sciences, Vol. 16, No. 10, 05.10.2015, p. 23651-23667.

Research output: Contribution to journalReview article

Archer, K, Broskova, Z, Bayoumi, AS, Teoh, JP, Davila, A, Tang, Y, Su, H & Kim, IM 2015, 'Long non-coding RNAs as master regulators in cardiovascular diseases', International journal of molecular sciences, vol. 16, no. 10, pp. 23651-23667. https://doi.org/10.3390/ijms161023651
Archer, Krystal ; Broskova, Zuzana ; Bayoumi, Ahmed S. ; Teoh, Jian Peng ; Davila, Alec ; Tang, Yaoliang ; Su, Huabo ; Kim, Il Man. / Long non-coding RNAs as master regulators in cardiovascular diseases. In: International journal of molecular sciences. 2015 ; Vol. 16, No. 10. pp. 23651-23667.
@article{cf03398de294417b89f05cfe1da97464,
title = "Long non-coding RNAs as master regulators in cardiovascular diseases",
abstract = "Cardiovascular disease is the leading cause of death in the United States, accounting for nearly one in every seven deaths. Over the last decade, various targeted therapeutics have been introduced, but there has been no corresponding improvement in patient survival. Since the mortality rate of cardiovascular disease has not been significantly decreased, efforts have been made to understand the link between heart disease and novel therapeutic targets such as non-coding RNAs. Among multiple non-coding RNAs, long non-coding RNA (lncRNA) has emerged as a novel therapeutic in cardiovascular medicine. LncRNAs are endogenous RNAs that contain over 200 nucleotides and regulate gene expression. Recent studies suggest critical roles of lncRNAs in modulating the initiation and progression of cardiovascular diseases. For example, aberrant lncRNA expression has been associated with the pathogenesis of ischemic heart failure. In this article, we present a synopsis of recent discoveries that link the roles and molecular interactions of lncRNAs to cardiovascular diseases. Moreover, we describe the prevalence of circulating lncRNAs and assess their potential utilities as biomarkers for diagnosis and prognosis of heart disease.",
keywords = "Chromatin, Epigenetic regulation, Gene regulation, Heart disease, Non-coding RNAs",
author = "Krystal Archer and Zuzana Broskova and Bayoumi, {Ahmed S.} and Teoh, {Jian Peng} and Alec Davila and Yaoliang Tang and Huabo Su and Kim, {Il Man}",
year = "2015",
month = "10",
day = "5",
doi = "10.3390/ijms161023651",
language = "English (US)",
volume = "16",
pages = "23651--23667",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Long non-coding RNAs as master regulators in cardiovascular diseases

AU - Archer, Krystal

AU - Broskova, Zuzana

AU - Bayoumi, Ahmed S.

AU - Teoh, Jian Peng

AU - Davila, Alec

AU - Tang, Yaoliang

AU - Su, Huabo

AU - Kim, Il Man

PY - 2015/10/5

Y1 - 2015/10/5

N2 - Cardiovascular disease is the leading cause of death in the United States, accounting for nearly one in every seven deaths. Over the last decade, various targeted therapeutics have been introduced, but there has been no corresponding improvement in patient survival. Since the mortality rate of cardiovascular disease has not been significantly decreased, efforts have been made to understand the link between heart disease and novel therapeutic targets such as non-coding RNAs. Among multiple non-coding RNAs, long non-coding RNA (lncRNA) has emerged as a novel therapeutic in cardiovascular medicine. LncRNAs are endogenous RNAs that contain over 200 nucleotides and regulate gene expression. Recent studies suggest critical roles of lncRNAs in modulating the initiation and progression of cardiovascular diseases. For example, aberrant lncRNA expression has been associated with the pathogenesis of ischemic heart failure. In this article, we present a synopsis of recent discoveries that link the roles and molecular interactions of lncRNAs to cardiovascular diseases. Moreover, we describe the prevalence of circulating lncRNAs and assess their potential utilities as biomarkers for diagnosis and prognosis of heart disease.

AB - Cardiovascular disease is the leading cause of death in the United States, accounting for nearly one in every seven deaths. Over the last decade, various targeted therapeutics have been introduced, but there has been no corresponding improvement in patient survival. Since the mortality rate of cardiovascular disease has not been significantly decreased, efforts have been made to understand the link between heart disease and novel therapeutic targets such as non-coding RNAs. Among multiple non-coding RNAs, long non-coding RNA (lncRNA) has emerged as a novel therapeutic in cardiovascular medicine. LncRNAs are endogenous RNAs that contain over 200 nucleotides and regulate gene expression. Recent studies suggest critical roles of lncRNAs in modulating the initiation and progression of cardiovascular diseases. For example, aberrant lncRNA expression has been associated with the pathogenesis of ischemic heart failure. In this article, we present a synopsis of recent discoveries that link the roles and molecular interactions of lncRNAs to cardiovascular diseases. Moreover, we describe the prevalence of circulating lncRNAs and assess their potential utilities as biomarkers for diagnosis and prognosis of heart disease.

KW - Chromatin

KW - Epigenetic regulation

KW - Gene regulation

KW - Heart disease

KW - Non-coding RNAs

UR - http://www.scopus.com/inward/record.url?scp=84943645643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943645643&partnerID=8YFLogxK

U2 - 10.3390/ijms161023651

DO - 10.3390/ijms161023651

M3 - Review article

C2 - 26445043

AN - SCOPUS:84943645643

VL - 16

SP - 23651

EP - 23667

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

ER -